Cv Sciences Stock Fundamentals
CVSI Stock | USD 0.04 0.00 0.00% |
CV Sciences fundamentals help investors to digest information that contributes to CV Sciences' financial success or failures. It also enables traders to predict the movement of CVSI OTC Stock. The fundamental analysis module provides a way to measure CV Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CV Sciences otc stock.
CVSI |
CV Sciences OTC Stock Operating Margin Analysis
CV Sciences' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current CV Sciences Operating Margin | (0.93) % |
Most of CV Sciences' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CV Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition |
Based on the recorded statements, CV Sciences has an Operating Margin of -0.9293%. This is 97.35% lower than that of the Personal Products sector and significantly lower than that of the Consumer Staples industry. The operating margin for all United States stocks is 83.13% lower than that of the firm.
CV Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CV Sciences's current stock value. Our valuation model uses many indicators to compare CV Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CV Sciences competition to find correlations between indicators driving CV Sciences's intrinsic value. More Info.CV Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value CV Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CV Sciences' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.CVSI Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CV Sciences' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of CV Sciences could also be used in its relative valuation, which is a method of valuing CV Sciences by comparing valuation metrics of similar companies.CV Sciences is currently under evaluation in operating margin category among its peers.
CVSI Fundamentals
Return On Equity | -2.36 | |||
Return On Asset | -0.52 | |||
Profit Margin | (0.85) % | |||
Operating Margin | (0.93) % | |||
Current Valuation | 5.53 M | |||
Shares Outstanding | 150.1 M | |||
Shares Owned By Insiders | 2.01 % | |||
Price To Earning | 54.89 X | |||
Price To Book | 3.57 X | |||
Price To Sales | 0.28 X | |||
Revenue | 20.05 M | |||
Gross Profit | 8.62 M | |||
EBITDA | (14.35 M) | |||
Net Income | (15.55 M) | |||
Cash And Equivalents | 1.11 M | |||
Cash Per Share | 0.01 X | |||
Total Debt | 1.4 M | |||
Debt To Equity | 0.74 % | |||
Current Ratio | 0.93 X | |||
Book Value Per Share | 0.01 X | |||
Cash Flow From Operations | (7.49 M) | |||
Earnings Per Share | (0.13) X | |||
Target Price | 0.05 | |||
Number Of Employees | 69 | |||
Beta | 1.0 | |||
Market Capitalization | 7.85 M | |||
Total Asset | 18.07 M | |||
Retained Earnings | (21.65 M) | |||
Working Capital | 12.83 M | |||
Current Asset | 15.84 M | |||
Current Liabilities | 3.01 M | |||
Z Score | 2.6 | |||
Net Asset | 18.07 M |
About CV Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CV Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CV Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CV Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.CV Sciences, Inc. operates as a life science company in North America. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California. Cv Sciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 69 people.
Currently Active Assets on Macroaxis
Other Information on Investing in CVSI OTC Stock
CV Sciences financial ratios help investors to determine whether CVSI OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CVSI with respect to the benefits of owning CV Sciences security.